2C-T-36
2C-T-36, also known as 2,5-dimethoxy-4-(trifluoromethylsulfanyl)phenethylamine or 2C-T-TFM as well as CYB210010 or CYB2108, is a psychedelic drug of the phenethylamine and 2C families.
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
2C-T-36, also known as 2,5-dimethoxy-4-(trifluoromethylsulfanyl)phenethylamine or 2C-T-TFM as well as CYB210010 or CYB2108, is a psychedelic drug of the phenethylamine and 2C families.
Use and effects
The properties and effects of 2C-T-36 in humans appear to be unknown.
Pharmacodynamics
2C-T-36 has a K i of 0.35 nM at the serotonin 5-HT 2A receptor, and an of 4.1 nM at the serotonin 5-HT 2A receptor and 7.3 nM at the serotonin 5-HT 2C receptor, compared to 88 nM at the serotonin 5-HT 2B receptor. It is a potent, selective, long acting, and orally active agonist for the serotonin 5-HT 2A and 5-HT 2C receptors and produces psychedelic-like responding in several different animal species.
The interactions of 2C-T-36 with numerous other receptors and targets have also been described.
Synthesis
The chemical synthesis of 2C-T-36 has been described.
Analogues
, a deuterated analogue of 2C-T-36 (CYB2108). Analogues of 2C-T-36 (2C-T-TFM) include 2C-T-21 (2C-T-FE), 2C-T-21.5 (2C-T-DFE), 2C-T-22 (2C-T-TFE), 2C-T-28 (2C-T-FP), 2C-T-35 (2C-T-DFM), 2C-T, 2C-TFM, and 2C-TFE, among others. Some other analogues include 2C-Se-TFM, trifluoromescaline (TFM), 3C-TFE (3C-trifluoroescaline), and tiflorex (flutiorex).
A deuterated isotopologue, CYB2108D (2C-T-36 with fully deuterated methoxy groups at 2 and 5 positions), is known.
History
Alexander Shulgin attempted to synthesise this compound in the 1990s, and mentions it in his book PiHKAL (Phenethylamines I Have Known and Loved) under the entry for 2C-T-21, but was unsuccessful in producing a key intermediate and never assigned it a 2C-T number. 2C-T-36 was ultimately first synthesised and named by Geoffrey Varty and colleagues at Irish biopharmaceutical company Helus Pharma (formerly Cybin) in 2023.
Canada
2C-T-36 is a controlled substance in Canada under phenethylamine blanket-ban language.
United States
The drug is not an explicitly controlled substance in the United States.
Research
Other related drugs under development by Helus Pharma (formerly Cybin) include the deuterated phenethylamine HLP005 (CYB005) and the deuterated tryptamines deupsilocin (HLP003; CYB003) and deudimethyltryptamine (HLP004; CYB004).
Text derived from https://en.wikipedia.org/w/index.php?oldid=1366895210 under CC BY-SA 4.0; modifications have been made.